- Home
- DTST vs ENLV Comparison
DTST vs ENLV Comparison
Compare DTST & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- ENLV
- Stock Information
- Founded
- DTST 2001
- ENLV 2005
- Country
- DTST United States
- ENLV Israel
- Employees
- DTST N/A
- ENLV N/A
- Industry
- DTST EDP Services
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- ENLV Health Care
- Exchange
- DTST Nasdaq
- ENLV Nasdaq
- Market Cap
- DTST 28.2M
- ENLV 23.7M
- IPO Year
- DTST N/A
- ENLV 1995
- Fundamental
- Price
- DTST $3.41
- ENLV $1.21
- Analyst Decision
- DTST
- ENLV Strong Buy
- Analyst Count
- DTST 0
- ENLV 2
- Target Price
- DTST N/A
- ENLV $10.00
- AVG Volume (30 Days)
- DTST 34.4K
- ENLV 83.7K
- Earning Date
- DTST 08-13-2025
- ENLV 05-30-2025
- Dividend Yield
- DTST N/A
- ENLV N/A
- EPS Growth
- DTST N/A
- ENLV N/A
- EPS
- DTST 0.02
- ENLV N/A
- Revenue
- DTST $25,219,312.00
- ENLV N/A
- Revenue This Year
- DTST $12.57
- ENLV N/A
- Revenue Next Year
- DTST $9.29
- ENLV N/A
- P/E Ratio
- DTST $142.68
- ENLV N/A
- Revenue Growth
- DTST N/A
- ENLV N/A
- 52 Week Low
- DTST $2.93
- ENLV $0.81
- 52 Week High
- DTST $6.95
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- DTST 41.10
- ENLV 69.48
- Support Level
- DTST $3.34
- ENLV $0.90
- Resistance Level
- DTST $3.48
- ENLV $1.30
- Average True Range (ATR)
- DTST 0.18
- ENLV 0.08
- MACD
- DTST -0.03
- ENLV 0.03
- Stochastic Oscillator
- DTST 21.92
- ENLV 77.50
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.